IL6 and neoplasm: Thus, our data in liver cancer cell lines are in line with previous studies in fibroblasts and ma-crophages whereby a disbalance between STAT1 and STAT3 may lead to the activation of IFN-γ/STAT1 target genes in a proinflammatory IL-6-containing tumor microenvironment.